Valuation GlaxoSmithKline Pharmaceuticals Limited

Stocks

Delayed Bombay S.E. Other stock markets 05:35:26 2026-07-02 am EDT			5-day change	1st Jan Change
2,419.25 ^INR	-1.79%		+2.54%	-2.12%

May. 29	GlaxoSmithKline Pharmaceuticals Limited Announces Resignation of Dr. Simrat Sohal from Compliance Officer and Ceases to Be the Senior Management Personnel, Effective August 5, 2026	CI
May. 13	GlaxoSmithKline Pharmaceuticals Clocks Higher Fiscal Q4 Consolidated Net Profit	MT

Data adjusted to current consolidation scope

Fiscal Period: March	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	281,714	224,319	329,173	487,432	386,822	417,315	-
Change	-	-20.37%	46.74%	48.08%	-20.64%	7.88%	-
Enterprise Value (EV)	256,351	207,663	329,173	487,432	386,822	417,315	417,315
Change	-	-18.99%	58.51%	48.08%	-20.64%	7.88%	0%
P/E	16.6x	36.7x	55.8x	52.5x	37.3x	36.6x	32.4x
PBR	10.6x	12.9x	18.5x	25x	17.1x	15.7x	13.3x
PEG	-	-0.6x	-16.49x	0.9x	3.2x	3.6x	2.5x
Capitalization / Revenue	8.59x	6.9x	9.53x	13x	10.1x	9.95x	8.98x
EV / Revenue	0x	0x	0x	0x	0x	9.95x	8.98x
EV / EBITDA	0x	0x	0x	0x	0x	28.4x	25x
EV / EBIT	0x	0x	0x	0x	0x	30.3x	26.5x
EV / FCF	0x	0x	0x	0x	0x	36x	32.5x
FCF Yield	2.75%	1.96%	1.67%	2.6%	2.19%	2.78%	3.08%
Dividend per Share ²	30	32	32	42	57	29.5	29.5
Rate of return	1.8%	2.42%	1.65%	1.46%	2.5%	1.2%	1.2%
EPS ²	100	36.05	34.83	54.76	61.15	67.3	75.97
Distribution rate	30%	88.8%	91.9%	76.7%	93.2%	43.8%	38.8%
Net sales ¹	32,780	32,517	34,537	37,492	38,217	41,939	46,453
EBITDA ¹	8,273	8,043	9,087	11,774	13,092	14,683	16,675
EBIT ¹	7,592	7,385	8,390	11,106	12,428	13,760	15,728
Net income ¹	16,947	6,107	5,900	9,276	10,360	11,402	12,873
Net Debt	-25,363	-16,656	-	-	-	-	-
Reference price ²	1,662.95	1,324.15	1,943.10	2,877.30	2,283.40	2,463.40	2,463.40
Nbr of stocks (in thousands)	169,406	169,406	169,406	169,406	169,406	169,406	-
Announcement Date	5/16/22	5/17/23	5/17/24	5/13/25	5/13/26	-	-

¹INR in Million²INR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
GLAXOSMITHKLINE PHARMACEUTICALS LIMITED	36.6x	-	-	1.2%	4.39B
ELI LILLY AND COMPANY	34.84x	12.66x	25.79x	0.57%	1,063B
JOHNSON & JOHNSON	27.14x	6.24x	16.98x	2.1%	611B
ABBVIE INC.	30.97x	7.43x	15.19x	2.76%	444B
ROCHE HOLDING AG	17.52x	4.36x	10.71x	3.05%	324B
ASTRAZENECA PLC	22.92x	4.81x	13.47x	1.81%	285B
NOVARTIS AG	21.57x	5.54x	13.39x	2.85%	283B
NOVO NORDISK A/S	14.31x	5.31x	10.9x	3.5%	219B
AMGEN INC.	23.55x	6.27x	11.03x	2.79%	195B
GILEAD SCIENCES, INC.	-44.98x	5.45x	30.27x	2.58%	156B
Average	18.44x	6.45x	16.41x	2.32%	358.51B
Weighted average by Cap.	24.14x	7.86x	18.13x	1.99%